Alcon AG
🇬🇧XLON.0A0DUnited KingdomHealthcare
Price$53.39-0.56 (-1.04%)
Latest anomalies
Neutral 0 detected in the last 120 days
- High: 3
- Medium: 0
- Low: 0
Dividend payout ratio: a sudden spike above its trailing quarter average
Gross profit margin: a sudden drop below its trailing quarter average
Net profit margin: a sudden drop below its trailing quarter average
Free with a Finzer account.
Profile
- Healthcare
- Medical Instruments & Supplies
- United Kingdom
Identity
- Exchange
- London Stock Exchange . XLON
- Type
- Stock
- ISIN
- CH0432492467
- CUSIP
- Not reported
Company
- Employees
- 25,000
- Headquarters
- Geneva, United States
- Website
- https://www.alcon.com
Market
- Shares outstanding
- 491.8M
- Market cap
- $31.89B
Highlights
- Market cap
- $31.89B
- EPS LTM
- $2.16
- P/E LTM
- 24.77calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- 0.62%calculatedCalculated by Finzer, not reported by the data provider.
Fundamentals (LTM)
- Revenue
- $10.03B+4.04%up year on year
- Net income
- $1.07B-2.63%down year on year
- Gross margin
- 55.13%-0.42%down year on year
- Free cash flow
- $1.62B+41.06%up year on year
Latest news
News is not sourced for this exchange.
Business summary
Alcon AG is a company in the healthcare sector, listed on London Stock Exchange (United Kingdom) under the ticker 0A0D. Its market capitalisation is $31.89B, from 491.8M shares outstanding, as of . Across the 252 trading sessions to the shares traded between $48.08 and $69.92, and the last close of $53.39 sits 24% of the way up that range. The company is headquartered in Geneva, United States, and employs about 25,000 people. This is the London Stock Exchange listing of Alcon AG; its primary listing is ALC on SIX Swiss Exchange.
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, grieshaber, MIVS instruments, scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.